July 14, 2020
Riding the merry-go-round, risk keeps the music playing and the horses revolving, no wonder they’re called “jumpers”
Pre-open indications: 5 BUYs and 3 SELLs
What I provide is an intelligence daily. Where are the canaries in the sector coal mine, am I the only one?
Subscription is coming, it’s not conscription but, an offer to join our collective of like-minded investors who make money and for those who read and don’t weep!
July 8, 2020
BLFS' underwriters' option included an additional 776,250 shares
The gross proceeds from the offering to BLFS, before deducting underwriting discounts and commissions and estimated offering expenses, were approximately $86 million.
July 14, 2020
Pre-open indications: 4 HIT and 4 MISS
An “intelligence newspaper” for smart investing in the RegMed, gene and cell therapy sector. Who is feeding your portfolio – profit from RMi’s analysis! Check the BOTTOM LINE … the facts and truth will make your portfolio profitable
Subscription is coming, it’s not a conscription but, an offer to join our collective of like-minded investors who make money and for those who read and don’t weep!
July 8, 2020
BLFS' underwriters' option included an additional 776,250 shares The gross proceeds from the offering to BLFS, before deducting underwriting discounts and commissions and estimated offering expenses, were approximately $86 million.
July 2, 2020
MDXG opened UP +0.08 at $5.40 Under the Securities Purchase Agreement, MDXG is issuing shares of a newly created Series B Convertible Preferred Stock for an aggregate purchase price of $100,000,000 with $90,000,000 being made by an entity controlled by EW Healthcare Partners and $10,000,000.
June 26, 2020
EDIT closed down -$2.49 (-7.93%) to $28.92 at the market close of the offering close EDIT had upped the 4 million share offering to 6 million, then sold 6.9 million shares which includes the greenshoe of 900 K shares Gross proceeds were $215.6 million
© 2020 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
